One Stop Solution For In-Depth Market Research Reports


Home    >    HEALTHCARE AND PHARMACEUTICALS   >   Urology Devices Market

[ 英語タイトル ] Urology Devices Market - Growth, Trends, and Forecast (2020 - 2025)

Product Code : MDHC0082321
Survey : Mordor Intelligence
Publish On : November, 2020
Category : Healthcare and Pharmaceuticals
Report format : PDF
Sales price option (consumption tax not included)
Single User USD4250 / Question Form
5 User USD4750 / Question Form
Enterprise User USD7500 / Question Form
 - Baxter International Inc.
- Boston Scientific Corporation
- Becton, Dickinson and Company
- Cook Medical Incorporated
- Dornier MedTech GmbH
- Fresenius Medical Care AG & Co. KGaA
- Intuitive Surgical Inc.
- Karl Storz SE & Co. KG
- Medtronic PLC
- Olympus Corporation
- Richard Wolf GmbH
- Siemens Healthcare GmbH
- Stryker Corporation

[Report Description]

The global urology devices market is found growing at a CAGR of 6.35% and the key factors propelling the market growth include high incidence of urologic conditions, rising geriatric population, and technological advancements.

According to the American Urological Association Foundation (AUAF), benign prostatic hyperplasia (BPH), urinary incontinence (UI), urinary tract infections (UTIS), and kidney and ureteral stones are among the most common urological diseases. According to the United States Department of Health and Human Services, the overall prevalence of CKD among the American population is about 14%, and almost half of the individuals with CKD suffer from diabetes and/or cardiovascular diseases. Annually, more than 661,000 Americans suffer from kidney failure, and 468,000 patients are given dialysis.

Urinary tract infections (UTIs) are one of the most common microbial diseases affecting people of all age groups. Globally, UTIs affect around 150 million people every year. Diabetic patients have a higher risk of developing UTIs and complications associated with it. With a global increase in diabetic population, complications, like dysuria and organ damage are associated with UTIs, that are also on the rise.

Hence, with the high incidence rates and health complications associated with urological diseases, there is an increasing demand for healthcare interventions to manage them, which, in turn, is propelling the market of urology devices market.

Key Market Trends

Kidney Disease is Expected to hold the Highest Market Share in the Disease Segment

The various kidney diseases includes renal cyst, cystic kidney diseases, chronic kidney disease, hemolytic-uremic syndrome, and lupus nephrite, among others. Most of the kidney diseases lead to kidney failure, which requires early diagnosis for prompt treatment.

According to the CDC data in 2016, there are nearly 125,000 people in the United States started treatment for end-stage kidney disease (ESKD), and more than 726,000 (2 in every 1,000 people) were on dialysis or were living with a kidney transplant. However, most of the population remain undiagnosed in the early stages, eventually leading to death, worldwide.

Therefore an increase in awareness, along with support from the government through reimbursement, and innovation in products, in order to develop low-cost and effective treatment, are some elements that are expected to drive the market, over the forecast period.

North America is Dominating the Market and is Expected to do the Same During the Forecast Period

North America currently dominates the market for urology devices and is expected to continue its stronghold for a few more years. Benign prostatic hyperplasia (BPH) is among the most untapped segments in the urology market, with several US-based companies working on upgrading their devices in this segment, either by collaboration or acquisition.

Recently, in 2018, Boston Scientific Corporation acquired NxThera and its Rezūm benign prostatic hyperplasia device. Additionally, several ventures partners, as well as other investors have funded significantly for minimally invasive devices for the treatment of urology diseases. For instance, Zenflow received USD 31.4 million funding, while UroCure, a medical device startup raised USD 2.5 million for urethral slings, in 2018. The technology was acquired by Endo International's subsidiary, American Medical Systems Holdings.

Thus, over the forecast period, technological advancements, a high percentage of urology cases in hospitals, and increasing funding are expected to be the major drivers for the growth of the urology devices market.

Competitive Landscape

The urology devices market is highly competitive and consists of several major players. With increasing technological advancements and product innovations, mid-size to smaller companies are expected to increase their market presence by introducing new devices with lesser prices. These companies, like Baxter, Boston Scientific, C. R. Bard, Medtronic, and Siemens, hold the substantial share in the market.

Reasons to Purchase this report:

- The market estimate (ME) sheet in Excel format
- 3 months of analyst support

1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study



4.1 Market Overview
4.2 Market Drivers
4.2.1 High Incidence of Urologic Conditions
4.2.2 Rising Geriatric Population
4.2.3 Technological Advancements
4.3 Market Restraints
4.3.1 Stringent Regulatory Policies for Validation of Medical Devices
4.3.2 High Cost of Urology Devices
4.4 Porter's Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry

5.1 By Product
5.1.1 Instruments Dialysis Devices Endoscopes and Endovision Systems Lasers and Lithotripsy Devices Robotic Systems Peripheral Instruments Others
5.1.2 By Consumables and Accessories Dialysis Consumables Guidewires and Catheters Surgical Dissectors, Forceps, and Needle Holders Retrieval Devices and Extractors Stents Biopsy Devices Tubes and Distal Attachments Other Consumables and Accessories
5.2 By Disease
5.2.1 Kidney Diseases
5.2.2 Urological Cancer and BPH
5.2.3 Pelvic Organ Prolapse
5.2.4 Other Diseases
5.3 By End User
5.3.1 Hospitals and Clinics
5.3.2 Dialysis Centers
5.3.3 Other End Users
5.4 Geography
5.4.1 North America United States Canada Mexico
5.4.2 Europe Germany United Kingdom France Italy Spain Rest of Europe
5.4.3 Asia-Pacific China Japan India Australia South Korea Rest of Asia-Pacific
5.4.4 Middle East & Africa GCC South Africa Rest of Middle East & Africa
5.4.5 South America Brazil Argentina Rest of South America

6.1 Company Profiles
6.1.1 Baxter International Inc.
6.1.2 Boston Scientific Corporation
6.1.3 Becton, Dickinson and Company
6.1.4 Cook Medical Incorporated
6.1.5 Dornier MedTech GmbH
6.1.6 Fresenius Medical Care AG & Co. KGaA
6.1.7 Intuitive Surgical Inc.
6.1.8 Karl Storz SE & Co. KG
6.1.9 Medtronic PLC
6.1.10 Olympus Corporation
6.1.11 Richard Wolf GmbH
6.1.12 Siemens Healthcare GmbH
6.1.13 Stryker Corporation




Recommended reports